NCT05551949View on ClinicalTrials.gov

Preventing Recurrent UTI With Vaginal Estrogen

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions
Recurrent Urinary Tract InfectionUrinary Tract InfectionsCystitis Recurrent
Interventions
DRUG

Vaginal estradiol tablets

Vaginal estradiol tablets (10mcg).

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

University of Maryland

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Johns Hopkins University

OTHER

NCT05551949 - Preventing Recurrent UTI With Vaginal Estrogen | Biotech Hunter | Biotech Hunter